Table 1.

Clinical characteristics of patients. All values are presented as n (percent) or mean ± SD.

CharacteristicsActive AOSD, n = 40Inactive AOSD, n = 16RA, n = 28HC, n = 27
Age, yrs42.5 ± 17.238.9 ± 15.648 ± 9.542.8 ± 10.5
Sex, F/M34/612/424/424/3
Symptom duration or disease duration, mos1.0 ± 0.68.6 ± 8.341.4 ± 27.7
Fever38 (95)0 (0)
Sore throat21 (52.5)0 (0)
Rash34 (85)1 (6.3)
Lymphadenopathy14 (35)0 (0)
Splenomegaly8 (20)0 (0)
Hepatomegaly7 (17.5)0 (0)
Pericarditis6 (15)0 (0)
Pleuritis5 (12.5)0 (0)
Arthralgia36 (90)2 (12.5)
Arthritis20 (50)1 (6.3)
Hemoglobin, g/dl11.2 ± 1.712.7 ± 1.712.9 ± 1.4
Leukocyte, /μl13,689 ± 49208256 ± 16607692.9 ± 3437
Platelet, ×103/μl307.3 ± 113.2258.3 ± 57.2253.8 ± 61.6
Ferritin, ng/ml6775.4 ± 10,307.6159.8 ± 206.1
ESR, mm/h57.8 ± 21.510.0 ± 8.728.5 ± 17.0
CRP, mg/dl8.76 ± 6.340.17 ± 0.190.93 ± 2.26
AST, mg/dl77.8 ± 64.323.9 ± 7.824.8 ± 10.6
ALT, mg/dl79.3 ± 92.223.1 ± 12.223.5 ± 18.0
Bilirubin, mg/dl0.70 ± 0.770.76 ± 0.330.58 ± 0.21
Albumin, g/dl3.70 ± 0.654.46 ± 0.224.44 ± 0.29
ANA positivity4 (10)7 (25)
RF positivity1 (2.5)26 (75)
Systemic score5.37 ± 1.300.19 ± 0.40
DAS283.87 ± 1.13
Methotrexate12 (75.0)18 (64.3)
Cyclosporine2 (12.5)0 (0)
Leflunomide0 (0)5 (17.8)
Hydroxychloroquine5 (31.3)22 (78.6)
Daily corticosteroid (mg prednisolone equivalent)5.86 ± 3.112.28 ± 1.87
  • The systemic scoring system of Pouchot, et al21 assigns a score from 0 to 12 with 1 point for each of the following manifestations: fever, typical rash, pleuritis, pneumonia, pericarditis, hepatomegaly or abnormal liver function test data, splenomegaly, lymphadenopathy, leukocytosis ≥ 15,000/mm2, sore throat, myalgia, and abdominal pain. AOSD: adult-onset Still’s disease; RA: rheumatoid arthritis; HC: healthy controls; LDH: lactate dehydrogenase; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; AST: aspartate transaminase; ALT: alanine transaminase; ANA: antinuclear antibody; RF: rheumatoid factor; DAS28: 28-joint Disease Activity Score.